Adeno-associated virus as a delivery vector for gene therapy of human diseases.

Overall, a trend of improvement in the treated patients versus placebo was observed; however, most outcome criteria did not reach statistical significance, except for left ventricular end-diastolic volume.

also in 111,027 other papers